Other Issues

Browse Other Issues Content

CHPA appreciates the opportunity to provide feedback on the notice requesting comments on the Inactive Ingredient Database (IID). Responses to each of the questions listed by FDA in the March 22, 2022 notice are provided.

Jun 21, 2022

Join Duffy MacKay, Senior Vice President of Dietary Supplements at CHPA, and George Paraskevakos, Executive Director of the International Probiotics Association to explore the science behind probiotics, why gut health is so important, and what’s next for this growing category.

Jun 13, 2022

Industry executives from Europe and beyond gathered June 7-8, in Madrid, Spain, for the annual meeting of the Association of the European Self-Care Industry (AESGP), its first annual meeting since 2019. Under the theme “supporting innovation in self-care during times of uncertainty,” speakers focused on the European context of environmental sustainability, trends shaping the future of the consumer healthcare business, and the outlook for changes to the EU’s pharmaceutical framework, among other topics.

Jun 9, 2022

Awareness of acetaminophen safe use and the risks of using too much remains high, indicating that ongoing education is critical to continued progress.

Jun 6, 2022

The Consumer Healthcare Products Association (CHPA) issued a statement from Duffy MacKay, Senior Vice President of Dietary Supplements, regarding a report from the U.S. Centers for Disease Control and Prevention (CDC) on Pediatric Melatonin Ingestions—United States, 2012-2021.

Jun 3, 2022

CHPA supports efforts to harmonize the current Quality System Regulation with international quality management system requirements. However, CHPA recommends that FDA address several points of concern or clarification when finalizing the Proposed Rule.

May 24, 2022

Filter Results